{"id":"NCT00343915","sponsor":"GlaxoSmithKline","briefTitle":"Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs","officialTitle":"Long-term Study of Immune Response Persistence of GSK Biologicals' 2-dose Thiomersal-free Engerix™-B and 3-dose Preservative-free Engerix™-B Vaccines in Subjects Aged 11-15 Yrs","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-04-21","primaryCompletion":"2008-01-10","completion":"2008-01-10","firstPosted":"2006-06-23","resultsPosted":"2009-03-31","lastUpdate":"2019-06-10"},"enrollment":267,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hepatitis B"],"interventions":[{"type":"BIOLOGICAL","name":"Engerix™-B (thiomersal-free) 20µg","otherNames":[]},{"type":"BIOLOGICAL","name":"10 μg Engerix™-B (preservative-free)","otherNames":[]},{"type":"BIOLOGICAL","name":"placebo","otherNames":[]}],"arms":[{"label":"2-Dose Engerix","type":"EXPERIMENTAL"},{"label":"3-Dose Engerix","type":"ACTIVE_COMPARATOR"}],"summary":"To evaluate the persistence of antibodies against hepatitis B at 30, 42, 54 and 66 months after the first dose of the hepatitis B primary vaccination course.\n\nSubjects were aged 11 to 15 years at the time of the primary vaccination course.\n\nAt the time of enrollment in the present long-term follow-up study subjects were aged 13 to 18 years.\n\nThe Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Number of Subjects Seroprotected for Anti-hepatitis B Surface Antigen (Anti-HBs) Antibody.","timeFrame":"At Month 7","effectByArm":[{"arm":"2-dose Engerix","deltaMin":233,"sd":null},{"arm":"3-dose Engerix","deltaMin":111,"sd":null}],"pValues":[]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":4,"countries":["Australia","Belgium","Ukraine"]},"refs":{"pmids":["17276552","12297392","21171982"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":257},"commonTop":["Pain; Across Doses","Pain; Dose 1","Pain; Dose 3","Headache; Across Doses","Fatigue; Across Doses"]}}